Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®)
BioDrugs - United Kingdom
doi 10.1007/s40259-014-0103-4
Full Text
Open PDFAbstract
Available in full text
Date
July 8, 2014
Authors
Publisher
Springer Science and Business Media LLC